Treating HIV infection with drugs for HSV-2 infection?

The Lancet

Volumn 375, Issue 9717, 2010, Pages 782-784

  Buvé, Anne ^a   Lynen, Lutgarde ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTHELMINTIC AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ISONIAZID; MULTIVITAMIN; VALACICLOVIR; VIRUS RNA;

AFRICA; ARTICLE; BED NET; CD4 LYMPHOCYTE COUNT; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFECT; DRUG EFFICACY; FOLLOW UP; HEALTH CARE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INDUSTRIALIZATION; MALARIA CONTROL; MIXED INFECTION; MORTALITY; NUTRITIONAL SUPPORT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL; VIRUS LOAD; VIRUS SHEDDING; WORLD HEALTH ORGANIZATION;

EID: 77649130865     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60097-9     Document Type: Note

References (17)

1. Lingappa J.R., Baeten J.M., Wald A., et al., for the Partners in Prevention HSV/HIV Transmission Study Team. Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 10.1016/S0140-6736(09)62038-9 published online Feb 15.
2. Nagot N., Ouédraogo A., Foulongne V., et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356 (2007) 790-809
3. Baeten J.M., Strick L.B., Lucchetti A., et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 198 (2008) 1804-1808
4. Dunne E.F., Whitehead S., Sternberg M., et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr 49 (2008) 77-83
5. Delany S., Mlaba N., Clayton T., et al. Impact of acyclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS 23 (2009) 461-469
6. Zuckerman R.A., Lucchetti A., Whittington W.L., et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS 23 (2009) 479-483
7. Celum C., Wald A., Lingappa J.R., et al., for the Partners in Prevention HSV/HIV Transmission Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362 (2010) 427-439
8. Ioannidis J., Collier A.C., Cooper D.A., et al. Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis 178 (1998) 349-359
9. WHO. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents (November, 2009). http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf (accessed Dec 12, 2009).
10. Campaign for Access to Essential Medicines, Médecins sans Frontières. Punishing success? Early signs of a retreat from commitment to HIV/AIDS care and treatment (Nov 5, 2009). http://www.msfaccess.org/fileadmin/user_upload/diseases/hiv-aids/11-05-REPORT_PunishingSuccess_A4_FINAL.pdf (accessed Jan 27, 2010).
11. Anglaret X., Chêne G., Attia A., et al., the Cotrimo-CI study. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 353 (1999) 1463-1468
12. Wiktor S.Z., Sassan-Morokro M., Grant A.D., et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 353 (1999) 1469-1475
13. Wilkinson D., Squire S.B., and Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ 317 (1998) 625-629
14. Fawzi W.W., Msamanga G.I., Spiegelman D., et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 351 (2004) 23-32
15. Manzi M., Zachariah R., Teck R., et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling up requires a different way of acting. Trop Med Int Health 10 (2005) 1242-1250
16. Kumar A., Kilaru K.R., Kumari G., Forde S., and Waterman I. Follow-up of HIV-infected women diagnosed by antenatal screening in Barbados from 1996-2004. AIDS Patient Care STDS 22 (2008) 715-721
17. Workowski K.A., and Berman S.M. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 55 (2006) 1-94